Latest news with #IlanaGolant
CBS News
2 days ago
- Health
- CBS News
Northwestern University scientists say asthma drug zileuton could stop life-threatening food allergies
Scientists at Northwestern University have found that a drug used for asthma could stop life-threatening food allergies by inhibiting a reaction in the first place. Researchers found the drug, zileuton, works to prevent food allergies in mice. Now they want to know if millions of humans can also benefit. Evanston native Ilana Golant never knew she had a food allergy until three years ago, when she got an anaphylactic reaction from inhaling sunflower butter. While she developed her allergies later in life, her 9-year-old daughter Emma has a list of food allergies that started at young age. "She developed anaphylactic food allergies at 13 months, and I knew absolutely nothing about food allergies," Golant said. Anaphylactic allergic reactions can be deadly, and require immediate attention. Golant says the worry weights on her daily, so she started the Food Allergy Fund, which gives money to research across the country. "Right now there is no FDA approved disease modifying drug available, period, for any patient," she said. But Northwestern University doctors Stephanie Eisenbarth and Adam Williams are leading a new study thanks to the fund. They found an asthma drug called zileuton could work. It's FDA approved and may be a safe, cheap and accessible option. "I think if I had said to a group of people, experts in food allergy, we want to trial this drug in food allergy, everyone would have said you're kind of crazy what are you doing?" Eisenbarth said. They are now running a new trial with more than 20 people from Chicago that started in June to see if the drug, which has so far worked in mice, will work in humans. "Obviously that has to be an incredibly controlled and safe environment so if someone needs epinephrine or more help it's available right away," she said. Eisenbarth said if zileuton is the future, it would prevent accidental exposures like on airplanes, at restaurants or at parties. It's not meant for everyday use, but Golant said it's also just the beginning. "We are probably going to need more tools in our toolbox because the disease is becoming more common and more prevalent," she said. There is no timeline yet on when we could expect to see zileuton offered to people for allergies. Doctors said researchers at Yale also found that the drug blocked allergies in animals as well.
Yahoo
22-05-2025
- Health
- Yahoo
Food Allergy Fund Supports Efforts to End Food Allergies and Other Chronic Diseases
Ilana Golant Statement on New White House Report NEW YORK, May 22, 2025--(BUSINESS WIRE)--The Food Allergy Fund applauds the release of the Make America Healthy Again report, which provides a roadmap for addressing the childhood chronic disease crisis, and thanks the MAHA Commission for prioritizing bold, science-driven solutions to address the health challenges, such as food allergies, that face our children. "Food allergies are a serious and rapidly growing public health crisis, affecting more than 33 million Americans—including 1 in 13 children and 1 in 10 adults. They serve as an early warning sign of broader chronic disease trends and sit at the critical intersection of food and agriculture, immune function, metabolic health, and the microbiome. By investing in research to better understand and address food allergies, we can unlock new insights with the potential to reshape the future of public health. "We commend the Administration's dedication to fostering innovation to tackle chronic disease and improve health in America. We appreciate the dialogue already underway with leadership and support collaboration to drive forward research that addresses the root causes of allergic disease and related conditions, delivering meaningful solutions for Americans." About the Food Allergy FundThe Food Allergy Fund (FAF) is the leading nonprofit dedicated to funding cutting-edge research to prevent, diagnose, and treat food allergies, a growing public health crisis affecting 10 percent of people in the United States and more than 300 million globally. Through innovative research grants and thought leadership summits, FAF is an incubator and convener, uniting scientists, policymakers, industry leaders, and entrepreneurs to drive breakthroughs. FAF's mission is to create a future where no one has to suffer from food allergies. To learn more, visit View source version on Contacts Media: Amy DiElsi; Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
